In early clinical progress (CT I), the primary aim is to provide the expected amounts of material rapidly As well as in reproducible quality.“It makes it tricky to suggest that bringing the many API manufacturing back again to your US and Europe solves the condition. It doesn’t if we can easily’t Regulate The full source chain.”•    Th